Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma…
OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon
Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Colgate Marks Historic Global Milestone: Over 2 Billion Children Benefiting from Colgate Bright Smiles, Bright Futures
Over 185 million children and families engaged pan India with significant partnerships…
Every Street is a Runway: From Streets to Pandals, Style Baazar Turns Every Step into a Showstopper Walk this Pujo
Celebrate Pujor Sera Saaj with festive fashion starting at just ₹149, across…
The h.wood Group Announces 9-Figure Valuation and Strategic Growth Investment from DIAFA, a New Abu Dhabi-based Luxury Hospitality Company
The multi-million investment to lead strategic growth of portfolio LOS ANGELES, Sept.…
SMIRNOFF AND TROYE SIVAN DROP NEW BUSINESS UPDATE FROM “VIBES HQ”, KICKING OFF ‘BRIEFCASE DROP’ SCAVENGER HUNT FOR FANS
Challenge to take place across L.A. in anticipation of International Vodka Day…
Track3D Secures $10 Mn Series A to Transform Construction Monitoring from Ironspring Ventures and Zacua Ventures
New capital to fuel hiring in India and deepen Track3D's AI innovation…
Kolmar Korea Advances ‘Clean Beauty’ with Breakthroughs from Eco-Friendly Packaging to R&D
Sweeps global awards with eco-friendly packaging innovations, including paper tube, paper stick,…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…